Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Future psoriasis therapy

M Lebwohl1

  • 1Division of Clinical Dermatology, The Mount Sinai School of Medicine, New York, New York, 10029-6574, USA.

Dermatologic Clinics
|October 1, 1995
PubMed
Summary
This summary is machine-generated.

New and emerging psoriasis treatments are reviewed, including recently approved therapies, novel combination regimens, and promising early-stage developments. This summary covers advancements for managing psoriasis effectively.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Disease Burden of Generalized Pustular Psoriasis: Real-World Evidence From CorEvitas' Psoriasis Registry.

Journal of psoriasis and psoriatic arthritis·2024
Same author

Efficacy and safety of tirbanibulin 1% ointment in actinic keratoses: Data from two phase-III trials and the real-life clinical practice presented at the European Academy of Dermatology and Venereology Congress 2022.

Journal of the European Academy of Dermatology and Venereology : JEADV·2023
Same author

Long-term safety of risankizumab from 17 clinical trials in patients with moderate-to-severe plaque psoriasis.

The British journal of dermatology·2021
Same author

Effect of baseline disease severity on achievement of treatment target with apremilast: results from a pooled analysis.

Journal of the European Academy of Dermatology and Venereology : JEADV·2021
Same author

Three-year efficacy and safety of certolizumab pegol for the treatment of plaque psoriasis: results from the randomized phase 3 CIMPACT trial.

Journal of the European Academy of Dermatology and Venereology : JEADV·2021
Same author

The risk of malignancy in patients with secukinumab-treated psoriasis, psoriatic arthritis and ankylosing spondylitis: analysis of clinical trial and postmarketing surveillance data with up to five years of follow-up.

The British journal of dermatology·2021
Same journal

Energy-Based Devices for Body Contouring.

Dermatologic clinics·2026
Same journal

Microfocused Ultrasound with Visualization for Skin Tightening: Clinical Applications, Safety, and Technical Considerations.

Dermatologic clinics·2026
Same journal

Devices in Onychomycosis: A Status Update.

Dermatologic clinics·2026
Same journal

Acne Laser Devices in Dermatology.

Dermatologic clinics·2026
Same journal

Fractional Laser Therapy for Androgenetic Alopecia: Mechanisms, Clinical Evidence, and Practical Implementation.

Dermatologic clinics·2026
Same journal

Microcoring.

Dermatologic clinics·2026
See all related articles

Area of Science:

  • Dermatology
  • Pharmacology

Background:

  • Psoriasis is a chronic autoimmune skin condition affecting millions globally.
  • Existing treatments offer varying efficacy and side effect profiles.
  • There is a continuous need for improved and novel therapeutic options.

Purpose of the Study:

  • To provide a comprehensive overview of recent advancements in psoriasis treatment.
  • To discuss emerging therapies and new applications of existing treatments.
  • To highlight potential future treatments in clinical and preclinical development.

Main Methods:

  • Literature review of recently published studies and clinical trial data.
  • Analysis of newly approved psoriasis medications and combination therapies.
  • Examination of ongoing research into novel therapeutic targets and approaches.

Related Experiment Videos

Main Results:

  • Several new systemic and biologic therapies have recently become available.
  • Novel combination regimens are showing promise for enhanced efficacy.
  • Early-stage research is exploring innovative treatment modalities, including gene therapy and microbiome modulation.

Conclusions:

  • The therapeutic landscape for psoriasis is rapidly evolving with numerous promising options.
  • Patients can expect a wider range of effective treatment choices in the near future.
  • Continued research is crucial for addressing unmet needs in psoriasis management.